Company news
Argent Biopharma Ltd news in 2016
Argent Biopharma Ltd's news releases, calls and decks from 2016, newest first.
MXC Operations Update
December 22, 2016
New Panax Acquisition Agreement Signed, Settlement Imminent
December 14, 2016
First Major European Sales and Revenue for MGC Derma Range
December 2, 2016
Cleansing Prospectus
November 9, 2016
EU Registration Commenced for CBD Derma Product Sales
November 6, 2016
September Quarter Activity and Cashflow Report
October 26, 2016
Operations Update - Multiple Revenue Streams Imminent
September 29, 2016
New Med Cannabis White Paper Developed with Uni of Sydney
September 21, 2016
Strategic Agreement signed with Epilepsy Action Australia
September 1, 2016
Appendix 4E and Audited 2016 Financial Report
August 29, 2016
Psoriasis and Acne Tests Advancing Ahead of Product Launch
August 23, 2016
Sale of Lingokoto and Bouroubourou Gold Exploration Assets
August 11, 2016
Leading Epilepsy Expert Joins MXC Strategic Advisory Board
July 13, 2016
First Revenues Received from Californian Cosmetics Deal
June 26, 2016
MXCs First Crops Planted at European CBD Production Farm
June 15, 2016
Health Canada Approves MGC Derma CBD Cosmetics
May 30, 2016
FDA Approval Granted and First US Distribution Deal Signed
May 24, 2016
Shareholder Priority Offer Closed Early - Oversubscribed
May 19, 2016
Prospectus - Priority Offer
May 16, 2016
Priority Offer Timetable - Update
May 12, 2016
Supplementary Prospectus
May 11, 2016
European Commission Approves MGC Derma Cosmetics Products
May 10, 2016
ASX Approval of Panax Transaction and Capital Raising Update
May 9, 2016
MXC to Raise $5.0m - Capital Raising Oversubscribed
May 4, 2016
MXC to Acquire Licensed European Medical Cannabis Company
April 27, 2016
Response to ASX Price Query
April 18, 2016
MXC to Enter Australian Medicinal Cannabis Market
April 4, 2016
Drilling started at Lingokoto gold project, Senegal
March 30, 2016
MXC Publishes First Australian Med Cannabis White Paper
March 28, 2016
MXC Secures First Cosmetics Sales Agreement
March 24, 2016
Agreement with SipNose takes MXC into Global Epilepsy Market
March 2, 2016
Legalisation of Medical Cannabis Fast Tracks Aus Opportunity
February 24, 2016
Reinstatement to Official Quotation (23/02/2016)
February 19, 2016
Suspension from official quotation
February 11, 2016
MGC to Collaborate with Leading University of Sydney Faculty
February 10, 2016